Anika Therapeutics | Текущие Активы





Текущие активы Изменить Дата
Abbott USD 26B 1.16B 2025-12
Agenus USD 133.95M 120.61M 2025-09
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Merit Medical Systems USD 1.04B 54.62M 2025-12
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 81.3M 948K 2024-09
Veracyte USD 488.38M 39.15M 2025-12
Xencor USD 599.82M 81.38M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12


Anika Therapeutics Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2026.